The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications

Abstract

OBJECTIVES: Evaluate the use of probiotics as an additional therapy in the treatment of children and adolescents with asthma in Belo Horizonte, MG-Brazil. METHODS: A pilot longitudinal, experimental and nonrandomized study with 30 patients from six to 17 years old from Belo Horizonte. In the baseline appointment, all patients received beclomethasone, and one group also received a probiotic containing Lactobacillus reuteri (n=14). The patients were reassessed after at least 60 days with the Asthma Control Test, spirometry and self-report of the symptoms they experienced associated with asthma. RESULTS: A predominance of male patients (56.7%) and a mean age of 10.6 years were observed. The groups using probiotics did not differ in terms of sex, age or atopy. In the longitudinal evaluation, an increase in the Asthma Control Test scores and a reduction in the number of symptoms were observed in the probiotic group. There was an increase in the peak expiratory flow among those who used probiotics. CONCLUSIONS: This pilot study supports the hypothesis that the administration of probiotics as a supplementary therapy for the treatment of children and adolescents with asthma improves the clinical condition of the patients. Further studies are needed to confirm the efficacy of probiotics in asthma treatment.

Considering Role of Probiotic on Respiratory Disease: Is Probiotic Possible to Treat COVID-19?

“…Giving probiotics as an adjunct therapy for the treatment of children and adolescents with asthma improves the patient's clinical condition. 9 Zeng et al, 2016 10 used open-label, randomized, controlled multicenter trial for 235 respondents critically ill adult patients expected to receive mechanical ventilation for ≥48 hours. Probiotics used contain Bacillus subtilis and Enterococcus faecalis (Medilac-S).…”

Limosilactobacillus reuteri DSM‐17938 for preventing cough in adults with mild allergic asthma: A double‐blind randomized placebo‐controlled cross‐over study

“…Only three studies using Lactobacillus reuteri in children have ever been conducted to evaluate asthma. A non‐randomized uncontrolled pilot study over 2 months showed improvement in the Asthma Control Test (ACT) and wheeze in children age 6–17; however, all children also received low‐dose inhaled steroids at baseline 52 . A randomized double‐blind placebo‐controlled study in children of Lactobacillus reuteri plus vitamin D3 compared with placebo found a significant reduction in fraction exhaled nitric oxide (FeNO) 53 .…”

Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases

“…In addition to L. rhamnosus , clinical studies have shown that Lactobacillus casei variety rhamnosus (Lc) can not only restore the number of intestinal probiotics ( Lactobacillus and Bifidobacterium ), regulate the gut microbiota, but also increase levels of secreted IgA by reducing intestinal inflammatory responses (e.g., fecal lactoferrin and calprotectin) [ 80 ]. What is more, a clinical trial showed that Lactobacillus reuteri enhanced the efficacy of beclomethasone in the treatment of asthma in children and adolescents, improved the Asthma Control Test scores, and increased the peak expiratory flow [ 81 ]. It is not difficult to see that Lactobacillus has clear potential effects against obesity, inflammatory hepatitis, anxiety depression, asthma, and tumors and relative clinical studies are still being carried out to confirm its real beneficial effect in the future.…”